Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma

被引：52

作者：

Flinsenberg, Thijs W. H. ^{[1
,2
]}

Tromedjo, Charnelle C. ^{[1
,2
]}

Hu, Nan ^{[3
]}

Liu, Ye ^{[3
]}

Guo, Yin ^{[3
]}

Thia, Kevin Y. T. ^{[1
,2
]}

Noori, Tahereh ^{[1
,2
]}

Song, Xiaomin ^{[3
]}

Aw Yeang, Han X. ^{[1
,2
,4
]}

Tantalo, Daniela G. ^{[1
,2
]}

Handunnetti, Sasanka ^{[5
,6
,7
]}

Seymour, John F. ^{[5
,6
,7
]}

Roberts, Andrew W. ^{[5
,6
,7
]}

Ritchie, David ^{[5
,6
,7
,8
,9
]}

Koldej, Rachel ^{[5
,8
,9
]}

Neeson, Paul J. ^{[1
,2
,4
]}

Wang, Lai ^{[3
]}

Trapani, Joseph A. ^{[1
,2
,4
]}

Tam, Constantine S. ^{[5
,6
,7
]}

Voskoboinik, Ilia ^{[1
,2
,4
]}

机构：

[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia

[2] Peter MacCallum Canc Ctr, Rosie Lew Immunotherapy Program, Melbourne, Vic, Australia

[3] BeiGene LTD, Beijing, Peoples R China

[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia

[5] Univ Melbourne, Fac Med Dent & Hlth Sci, Parkville, Vic, Australia

[6] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia

[7] Royal Melbourne Hosp, Melbourne, Vic, Australia

[8] ACRF Translat Res Lab, Parkville, Vic, Australia

[9] Royal Melbourne Hosp, Parkville, Vic, Australia

来源：

HAEMATOLOGICA | 2020年 / 105卷 / 02期

基金：

英国医学研究理事会;

关键词：

D O I：

10.3324/haematol.2019.220590

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E76 / E79

页数：4

共 15 条

[1] Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy [J].

Da Roit, Fabio ;

Engelberts, Patrick J. ;

Taylor, Ronald P. ;

Breij, Esther C. W. ;

Gritti, Giuseppe ;

Rambaldi, Alessandro ;

Introna, Martino ;

Parren, Paul W. H. I. ;

Beurskens, Frank J. ;

Golay, Josee .

HAEMATOLOGICA, 2015, 100 (01) :77-86

[2] Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes [J].

Dubovsky, Jason A. ;

Beckwith, Kyle A. ;

Natarajan, Gayathri ;

Woyach, Jennifer A. ;

Jaglowski, Samantha ;

Zhong, Yiming ;

Hessler, Joshua D. ;

Liu, Ta-Ming ;

Chang, Betty Y. ;

Larkin, Karilyn M. ;

Stefanovski, Matthew R. ;

Chappell, Danielle L. ;

Frissora, Frank W. ;

Smith, Lisa L. ;

Smucker, Kelly A. ;

Flynn, Joseph M. ;

Jones, Jeffrey A. ;

Andritsos, Leslie A. ;

Maddocks, Kami ;

Lehman, Amy M. ;

Furman, Richard ;

Sharman, Jeff ;

Mishra, Anjali ;

Caligiuri, Michael A. ;

Satoskar, Abhay R. ;

Buggy, Joseph J. ;

Muthusamy, Natarajan ;

Johnson, Amy J. ;

Byrd, John C. .

BLOOD, 2013, 122 (15) :2539-2549

[3] The Broad Spectrum of Human Natural Killer Cell Diversity [J].

Freud, Aharon G. ;

Mundy-Bosse, Bethany L. ;

Yu, Jianhua ;

Caligiuri, Michael A. .

IMMUNITY, 2017, 47 (05) :820-833

[4] CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells [J].

Juelke, Kerstin ;

Killig, Monica ;

Luetke-Eversloh, Merlin ;

Parente, Eliana ;

Gruen, Joachim ;

Morandi, Barbara ;

Ferlazzo, Guido ;

Thiel, Andreas ;

Schmitt-Knosalla, Isabela ;

Romagnani, Chiara .

BLOOD, 2010, 116 (08) :1299-1307

[5] Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk [J].

Khurana, Dianne ;

Arneson, Laura N. ;

Schoon, Renee A. ;

Dick, Christopher J. ;

Leibson, Paul J. .

JOURNAL OF IMMUNOLOGY, 2007, 178 (06) :3575-3582

[6] Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity [J].

Kohrt, Holbrook E. ;

Sagiv-Barfi, Idit ;

Rafiq, Sarwish ;

Herman, Sarah E. M. ;

Butchar, Jonathon P. ;

Cheney, Carolyn ;

Zhang, Xiaoli ;

Buggy, Joseph J. ;

Muthusamy, Natarajan ;

Levy, Ronald ;

Johnson, Amy J. ;

Byrd, John C. .

BLOOD, 2014, 123 (12) :1957-1960

[7]

Kuo H, 2016, BLOOD, V126, P4140

[8] Functional significance of CD57 expression on human NK cells and relevance to disease [J].

Nielsen, Carolyn M. ;

White, Matthew J. ;

Goodier, Martin R. ;

Riley, Eleanor M. .

FRONTIERS IN IMMUNOLOGY, 2013, 4

[9] Three BTK-Specific Inhibitors, in Contrast to Ibrutinib, Do Not Antagonize Rituximab-Dependent NK-Cell Mediated Cytotoxicity [J].

Rajasekaran, Narendiran ;

Sadaram, Mohith ;

Hebb, Jonathan ;

Sagiv-Barfi, Idit ;

Ambulkar, Sid ;

Rajapaksa, Amanda ;

Chang, Serena ;

Chester, Cariad ;

Waller, Erin ;

Wang, Lai ;

Lannutti, Brian ;

Johnson, Dave ;

Levy, Ron ;

Kohrt, Holbrook E. .

BLOOD, 2014, 124 (21)

[10] 5-Aminomethylbenzimdazoles as potent ITK antagonists [J].

Riether, Doris ;

Zindell, Renee ;

Kowalski, Jennifer A. ;

Cook, Brian N. ;

Bentzien, Joerg ;

De Lombaert, Stephane ;

Thomson, David ;

Kugler, Stanley Z., Jr. ;

Skow, Donna ;

Martin, Leslie S. ;

Raymond, Ernest L. ;

Khine, Hnin Hnin ;

O'Shea, Kathy ;

Woska, Joseph R., Jr. ;

Jeanfavre, Deborah ;

Sellati, Rosemarie ;

Ralph, Kerry L. M. ;

Ahlberg, Jennifer ;

Labissiere, Gabriel ;

Kashem, Mohammed A. ;

Pullen, Steven S. ;

Takahashi, Hidenori .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (06) :1588-1591

← 1 2 →